| Azioni degli insider | 25.612.643 shares |
| Numero totale di insider | 38 |
Indice del sentiment degli insider
L'indice del sentiment degli insider identifica le società le cui azioni vengono acquistate dagli insider aziendali.
È il risultato di un sofisticato modello quantitativo multi-fattore che identifica le società con i più alti livelli di accumulo di insider. Il modello di punteggio utilizza una combinazione del numero netto di acquisti degli insider negli ultimi 90 giorni, delle azioni totali acquistate in percentuale del flottante e delle azioni totali possedute dagli insider. Il punteggio varia da 0 a 100: i numeri più alti indicano un livello di accumulo superiore ad altre società, mentre 50 rappresenta la media.
Frequenza di aggiornamento: giornaliera
Indice del sentiment dei dirigenti
L'indice del sentiment dei dirigenti identifica le società le cui azioni vengono acquistate dai dirigenti aziendali.
Per definizione, i dirigenti aziendali sono insider della società, ma a differenza di altri insider (azionisti al 10% e membri del consiglio di amministrazione), i dirigenti lavorano quotidianamente per la società e utilizzano il proprio denaro quando fanno trading (gli azionisti al 10% e i membri del consiglio di amministrazione sono spesso gestori di fondi che gestiscono il denaro di altre persone). Pertanto, le operazioni di insider trading effettuate dai dirigenti sono molto più significative e devono essere trattate in modo appropriato.
Come l'indice del sentiment degli insider, l'indice del sentiment dei dirigenti è il risultato di un sofisticato modello quantitativo multi-fattore che identifica le società con i più alti livelli di accumulo di dirigenti.
Frequenza di aggiornamento: giornaliera
Principali indicatori per gli insider
Questa scheda mostra il posizionamento della società in base a diversi indicatori di insider. Il grado percentile mostra come la società si colloca rispetto alle altre società dei mercati statunitensi. Posizioni più alte indicano situazioni migliori.
Ad esempio, è generalmente accettato che gli acquisti di insider siano un indicatore positivo, per cui le società con un maggior numero di acquisti di insider si classificherebbero più in alto rispetto a quelle con un minor numero di acquisti di insider (o addirittura di vendite di insider).
Percentuale del flottante acquistato dagli insider (classifica)
N/A
La percentuale del flottante acquistato dagli insider è data dal numero totale di azioni acquistate dagli insider meno il numero totale di azioni vendute dagli insider negli ultimi 90 giorni, divisa per il flottante totale e moltiplicata per 100.
Grafico sull'insider trading
Il grafico seguente mostra le operazioni di insider trading di Bicycle Therapeutics plc - Depositary Receipt (Common Stock). Gli insider sono funzionari, direttori o investitori importanti di una società. In generale, è illegale per gli insider effettuare operazioni di compravendita nelle loro aziende sulla base di informazioni materiali non pubbliche. Ciò non significa che sia illegale per loro effettuare qualsiasi operazioni di trading nelle proprie aziende. Tuttavia, devono segnalare tutte le operazioni alla SEC tramite un modulo 4.
Lista degli insider e indicatori di redditività
Questa tabella mostra la lista degli insider noti ed è generata automaticamente a partire dai depositi effettuati presso la SEC. Oltre ai nomi, al titolo più recente e alla designazione di amministratore, funzionario o proprietario al 10%, forniamo le ultime partecipazioni divulgate. Inoltre, quando possibile, forniamo la performance storica delle transazioni dell'insider. La performance storica delle transazioni è una media ponderata della performance delle operazioni di acquisto sul mercato aperto effettuate dall'insider. Per maggiori informazioni su come viene calcolata, guarda questo webinar su YouTube.
See our leaderboard of most profitable insider traders.
| Insider | Utile medio (%) | Azioni possedute |
Rettificato per il frazionamento azionario |
|---|---|---|---|
|
Aquila Investments Iv
10% Owner -
|
1.957.961 | 1.957.961 | |
| Michael Anstey Director - [D] | 1.751.437 | 1.751.437 | |
| Santiago Arroyo CHIEF DEVELOPMENT OFFICER - [O] | 69.057 | 69.057 | |
|
Baker Bros. Advisors Lp
Director, 10% Owner -
[D]
|
9.999.674 | 9.999.674 | |
| Kate Bingham Director - [D] | 38.708 | 38.708 | |
| Janice Bourque Director - [D] | 23.000 | 23.000 | |
|
Innovation Capital (Jersey) Ltd Cambridge
10% Owner -
|
1.751.437 | 1.751.437 | |
| Nigel Crockett CHIEF BUSINESS OFFICER - [O] | 51.053 | 51.053 | |
|
Plc Glaxosmithkline
10% Owner -
|
1.910.531 | 1.910.531 | |
| Jose-Carlos Gutierrez-Ramos Director - [D] | 23.000 | 23.000 | |
| Deborah Harland Director - [D] | 1.915.275 | 1.915.275 | |
| Michael Charles Ferguson Hannay CHIEF PROD & SUPPLY CHAIN OFF - [O] | 53.825 | 53.825 |
| Insider | Utile medio (%) | Azioni possedute |
Rettificato per il frazionamento azionario |
|---|---|---|---|
| Veronica GH Jordan Director - [D] | 16.750 | 16.750 | |
| Lee Kalowski President and CFO - [O] | 30.309 | 30.309 | |
| Nicholas Keen CHIEF SCIENTIFIC OFFICER - [O] | 62.024 | 62.024 | |
| Richard N Kender Director - [D] | 23.000 | 23.000 | |
| Kevin Lee CHIEF EXECUTIVE OFFICER, Director - [D] [O] | 480.804 | 480.804 | |
| Pierre Legault Director - [D] | 46.000 | 46.000 | |
| Peter Brian Leone | 43.269 | ||
| Alistair Milnes CHIEF OPERATING OFFICER - [O] | 95.502 | 95.502 | |
| Carolyn Ng Director - [D] | 1.427.151 | 1.427.151 | |
|
Ag Novartis
10% Owner -
|
1.769.641 | 1.769.641 | |
|
Bioventures Ltd Novartis
10% Owner -
|
1.769.641 | 1.769.641 | |
| Alessandro Riva Director - [D] | 12.500 | 12.500 | |
|
Sv Life Sciences Fund V Lp
10% Owner -
|
39.637 | 39.637 |
| Insider | Utile medio (%) | Azioni possedute |
Rettificato per il frazionamento azionario |
|---|---|---|---|
|
SV Life Sciences Fund V (GP), LP
10% Owner -
|
39.637 | 39.637 | |
|
SV Life Sciences Fund V Strategic Partners, L.P.
10% Owner -
|
39.637 | 39.637 | |
|
Svlsf V, Llc
10% Owner -
|
39.637 | 39.637 | |
| Sands Stephen H. Director - [D] | 17.393 | 17.393 | |
| Michael Skynner CHIEF TECHNOLOGY OFFICER - [O] | 120.079 | 120.079 | |
| Dominic Smethurst Chief Medical Officer - [O] | 36.699 | 36.699 | |
| Robert Charles Swanton Director - [D] | 3.089 | 3.089 | |
|
Capital Management Hk Ltd Tybourne
10% Owner -
|
1.957.961 | 1.957.961 | |
| Travis Alvin Thompson CHIEF ACCOUNTING OFFICER - [O] | 31.521 | 31.521 | |
|
Vertex Global Healthcare Fund I Pte Ltd.
10% Owner -
|
1.621.168 | 1.621.168 | |
| Eric Westin Chief Medical Officer - [O] | 2.305 | 2.305 | |
| Gregory Paul Winter Director - [D] | 186.927 | 186.927 | |
| Alethia Young Chief Financial Officer - [O] | 45.186 | 45.186 |
Report errors via our new Insider Auditing Tool
Storico degli acquisti di insider - Analisi degli utili a breve termine
In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider effettuato sul mercato aperto in BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock). Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici .
La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.
Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Le azioni rettificate sono le azioni rettificate per il frazionamento azionario.
Storico delle vendite di insider - Analisi delle perdite a breve termine
In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock). Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici .
La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.
Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Le azioni rettificate sono le azioni rettificate per il frazionamento azionario.
Storico delle transazioni
Clicca sull'icona del link per visualizzare la cronologia completa delle transazioni. Le transazioni segnalate come parte di un piano di trading automatico 10b5-1 saranno contrassegnate con una X nella colonna contrassegnata con 10b-5.
| Data di deposito |
Data dell' operazione |
Modulo | Insider | Ticker | Titolo | Codice | Diretto | Prezzo di esercizio |
Prezzo unitario |
Unità modificate |
Valore modificato (1K) |
Opzioni rimanenti |
Azioni rimanenti |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-14 | 2025-08-12 | 4 | Swanton Robert Charles | BCYC | Ordinary Shares | D | 12.500 | 15.589 | ||||||
| 2025-08-14 | 3 | Swanton Robert Charles | BCYC | Ordinary Shares | D | 3.089 | ||||||||
| 2025-07-07 | 2025-07-02 | 4 | Young Alethia | BCYC | Ordinary Shares | D | 7,0900 | -204 | -1 | 45.186 | ||||
| 2025-07-07 | 2025-07-03 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 7,4400 | -100 | -1 | 31.521 | ||||
| 2025-07-07 | 2025-07-02 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 7,0900 | -206 | -1 | 31.621 | ||||
| 2025-07-07 | 2025-07-03 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 7,4400 | -248 | -2 | 53.825 | ||||
| 2025-07-07 | 2025-07-02 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 7,0900 | -474 | -3 | 54.073 | ||||
| 2025-07-07 | 2025-07-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 7,4400 | -966 | -7 | 95.502 | ||||
| 2025-07-07 | 2025-07-02 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 7,0900 | -1.149 | -8 | 96.468 | ||||
| 2025-07-07 | 2025-07-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 7,4400 | -966 | -7 | 120.079 | ||||
| 2025-07-07 | 2025-07-02 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 7,0900 | -825 | -6 | 121.045 | ||||
| 2025-07-07 | 2025-07-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 7,4400 | -3.193 | -24 | 480.804 | ||||
| 2025-07-07 | 2025-07-02 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 7,0900 | -2.268 | -16 | 483.997 | ||||
| 2025-04-04 | 2025-04-03 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 7,4800 | -109 | -1 | 31.827 | ||||
| 2025-04-04 | 2025-04-02 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 8,0200 | -210 | -2 | 31.936 | ||||
| 2025-04-04 | 2025-04-03 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 7,4800 | -266 | -2 | 54.547 | ||||
| 2025-04-04 | 2025-04-02 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 8,0200 | -467 | -4 | 54.813 | ||||
| 2025-04-04 | 2025-04-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 7,4800 | -3.432 | -26 | 486.265 | ||||
| 2025-04-04 | 2025-04-02 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 8,0200 | -2.237 | -18 | 489.697 | ||||
| 2025-04-04 | 2025-04-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 7,4800 | -1.038 | -8 | 97.617 | ||||
| 2025-04-04 | 2025-04-02 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 8,0200 | -1.133 | -9 | 98.655 | ||||
| 2025-04-04 | 2025-04-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 7,4800 | -1.038 | -8 | 121.870 | ||||
| 2025-04-04 | 2025-04-02 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 8,0200 | -814 | -7 | 122.908 | ||||
| 2025-04-04 | 2025-04-02 | 4 | Young Alethia | BCYC | Ordinary Shares | D | 8,0200 | -215 | -2 | 45.390 | ||||
| 2025-03-27 | 2025-03-25 | 4 | Riva Alessandro | BCYC | Ordinary Shares | D | 12.500 | 12.500 | ||||||
| 2025-03-27 | 3 | Westin Eric | BCYC | Ordinary Shares | D | 2.305 | ||||||||
| 2025-01-06 | 2025-01-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 14,7500 | -936 | -14 | 99.788 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 14,0900 | -4.578 | -65 | 100.724 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 35.000 | 105.302 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | Kender Richard N | BCYC | Ordinary Shares | D | 6.250 | 23.000 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | Sands Stephen H. | BCYC | Ordinary Shares | D | 5.393 | 17.393 | ||||||
| 2025-01-06 | 2025-01-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,7500 | -3.092 | -46 | 491.934 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0900 | -9.038 | -127 | 495.026 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 123.200 | 504.064 | ||||||
| 2025-01-06 | 2025-01-03 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 14,7500 | -239 | -4 | 55.280 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 14,0900 | -1.879 | -26 | 55.519 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 35.000 | 57.398 | ||||||
| 2025-01-06 | 2025-01-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 14,7500 | -936 | -14 | 123.722 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 14,0900 | -3.287 | -46 | 124.658 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 35.000 | 127.945 | ||||||
| 2025-01-06 | 2025-01-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 14,7500 | -936 | -14 | 51.053 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 14,0900 | -2.583 | -36 | 51.989 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 8.750 | 54.572 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | Arroyo Santiago | BCYC | Ordinary Shares | D | 14,0900 | -4.943 | -70 | 69.057 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Arroyo Santiago | BCYC | Ordinary Shares | D | 35.000 | 74.000 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | Young Alethia | BCYC | Ordinary Shares | D | 14,0900 | -1.395 | -20 | 45.605 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Young Alethia | BCYC | Ordinary Shares | D | 35.000 | 47.000 | ||||||
| 2025-01-06 | 2025-01-06 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 15,0000 | -2.686 | -40 | 32.146 | ||||
| 2025-01-06 | 2025-01-03 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 14,7500 | -159 | -2 | 34.832 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 14,0900 | -1.750 | -25 | 34.991 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 17.500 | 36.741 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 12.500 | 46.000 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | Bourque Janice | BCYC | Ordinary Shares | D | 6.250 | 23.000 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | Winter Gregory Paul | BCYC | Ordinary Shares | D | 6.250 | 186.927 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | Gutierrez-Ramos Jose-Carlos | BCYC | Ordinary Shares | D | 6.250 | 23.000 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 4.400 | 9.999.674 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 4.400 | 918.483 | ||||||
| 2024-12-17 | 2024-12-16 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 15,3418 | 457.631 | 7.021 | 9.995.274 | ||||
| 2024-12-17 | 2024-12-16 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 15,3418 | 42.369 | 650 | 914.083 | ||||
| 2024-12-17 | 2024-12-13 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 13,8040 | 566.814 | 7.824 | 9.537.643 | ||||
| 2024-12-17 | 2024-12-13 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 13,8040 | 52.656 | 727 | 871.714 | ||||
| 2024-12-17 | 2024-12-13 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 13,7242 | 244.587 | 3.357 | 8.970.829 | ||||
| 2024-12-17 | 2024-12-13 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 13,7242 | 22.722 | 312 | 819.058 | ||||
| 2024-12-17 | 2024-12-13 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 13,6288 | 59.995 | 818 | 8.726.242 | ||||
| 2024-12-17 | 2024-12-13 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 13,6288 | 5.573 | 76 | 796.336 | ||||
| 2024-12-17 | 2024-12-13 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 13,4979 | 30.241 | 408 | 8.666.247 | ||||
| 2024-12-17 | 2024-12-13 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 13,4979 | 2.809 | 38 | 790.763 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 24,8200 | -231 | -6 | 19.241 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 24,7700 | -209 | -5 | 19.472 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 25,2100 | -3.241 | -82 | 19.681 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 25,0500 | -1.109 | -28 | 22.922 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 9,8200 | 1.109 | 11 | 24.031 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 25,0100 | -154 | -4 | 22.922 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 8,2100 | 154 | 1 | 23.076 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 25,0500 | -1.312 | -33 | 22.922 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 1,8700 | 1.312 | 2 | 24.234 | ||||
| 2024-10-04 | 2024-10-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 22,2600 | -972 | -22 | 70.302 | ||||
| 2024-10-04 | 2024-10-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 22,2600 | -972 | -22 | 92.945 | ||||
| 2024-10-04 | 2024-10-03 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 22,2600 | -247 | -5 | 22.398 | ||||
| 2024-10-04 | 2024-10-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 22,2600 | -3.212 | -71 | 380.864 | ||||
| 2024-10-04 | 2024-10-03 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 22,2600 | -153 | -3 | 22.922 | ||||
| 2024-10-04 | 2024-10-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 22,2600 | -972 | -22 | 45.822 | ||||
| 2024-07-08 | 2024-07-03 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 19,6400 | -246 | -5 | 22.645 | ||||
| 2024-07-08 | 2024-07-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 19,6400 | -967 | -19 | 71.274 | ||||
| 2024-07-08 | 2024-07-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 19,6400 | -3.194 | -63 | 384.076 | ||||
| 2024-07-08 | 2024-07-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 19,6400 | -967 | -19 | 46.794 | ||||
| 2024-07-08 | 2024-07-03 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 19,6400 | -779 | -15 | 62.024 | ||||
| 2024-07-08 | 2024-07-03 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 19,6400 | -148 | -3 | 23.075 | ||||
| 2024-07-08 | 2024-07-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 19,6400 | -967 | -19 | 93.917 | ||||
| 2024-06-20 | 2024-06-17 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 2.186.686 | 8.636.006 | ||||||
| 2024-06-20 | 2024-06-17 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 196.098 | 787.954 | ||||||
| 2024-04-22 | 2024-04-18 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 12.000 | 6.449.320 | ||||||
| 2024-04-22 | 2024-04-18 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 12.000 | 6.449.320 | ||||||
| 2024-04-18 | 3 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 6.437.320 | ||||||||
| 2024-04-18 | 3 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 579.856 | ||||||||
| 2024-04-12 | 2024-04-11 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 22,4900 | -257 | -6 | 22.891 | ||||
| 2024-04-05 | 2024-04-03 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 23,8100 | -152 | -4 | 23.223 | ||||
| 2024-04-05 | 2024-04-03 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 23,8100 | -790 | -19 | 62.803 | ||||
| 2024-04-05 | 2024-04-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 23,8100 | -955 | -23 | 47.761 | ||||
| 2024-04-05 | 2024-04-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 23,8100 | -955 | -23 | 72.241 | ||||
| 2024-04-05 | 2024-04-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 23,8100 | -955 | -23 | 94.884 | ||||
| 2024-04-05 | 2024-04-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 23,8100 | -3.158 | -75 | 387.270 | ||||
| 2024-03-21 | 3 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 23.148 | ||||||||
| 2024-02-21 | 2024-02-20 | 4 | Sands Stephen H. | BCYC | Ordinary Shares | D | 12.000 | 12.000 | ||||||
| 2024-02-08 | 2024-02-06 | 4 | Arroyo Santiago | BCYC | Ordinary Shares | D | 21.660 | 39.000 | ||||||
| 2024-01-04 | 2024-01-03 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 17,5000 | -604 | -11 | 23.375 | ||||
| 2024-01-04 | 2024-01-02 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 16.000 | 23.979 | ||||||
| 2024-01-04 | 2024-01-02 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 12.000 | 33.500 | ||||||
| 2024-01-04 | 2024-01-03 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 17,5000 | -2.640 | -46 | 63.593 | ||||
| 2024-01-04 | 2024-01-02 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 28.000 | 66.233 | ||||||
| 2024-01-04 | 2024-01-02 | 4 | Bourque Janice | BCYC | Ordinary Shares | D | 6.000 | 16.750 | ||||||
| 2024-01-04 | 2024-01-02 | 4 | Gutierrez-Ramos Jose-Carlos | BCYC | Ordinary Shares | D | 6.000 | 16.750 | ||||||
| 2024-01-04 | 2024-01-02 | 4 | Winter Gregory Paul | BCYC | Ordinary Shares | D | 6.000 | 180.677 | ||||||
| 2024-01-04 | 2024-01-02 | 4 | Jordan Veronica GH | BCYC | Ordinary Shares | D | 6.000 | 16.750 | ||||||
| 2024-01-04 | 2024-01-02 | 4 | Kender Richard N | BCYC | Ordinary Shares | D | 6.000 | 16.750 | ||||||
| 2024-01-04 | 2024-01-02 | 4 | Arroyo Santiago | BCYC | Ordinary Shares | D | 17.340 | 17.340 | ||||||
| 2024-01-04 | 2024-01-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 17,5000 | -2.643 | -46 | 48.716 | ||||
| 2024-01-04 | 2024-01-02 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 22.000 | 51.359 | ||||||
| 2024-01-04 | 2024-01-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 17,5000 | -2.643 | -46 | 73.196 | ||||
| 2024-01-04 | 2024-01-02 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 39.000 | 75.839 | ||||||
| 2024-01-04 | 2024-01-02 | 4 | Young Alethia | BCYC | Ordinary Shares | D | 12.000 | 12.000 | ||||||
| 2024-01-04 | 2024-01-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 17,5000 | -8.703 | -152 | 390.428 | ||||
| 2024-01-04 | 2024-01-02 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 77.000 | 399.131 | ||||||
| 2024-01-04 | 2024-01-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 17,5000 | -2.643 | -46 | 95.839 | ||||
| 2024-01-04 | 2024-01-02 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 28.000 | 98.482 | ||||||
| 2023-10-05 | 2023-10-03 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 20,0000 | -54 | -1 | 7.979 | ||||
| 2023-10-05 | 2023-10-03 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 20,0000 | -272 | -5 | 38.233 | ||||
| 2023-10-05 | 2023-10-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 20,0000 | -442 | -9 | 29.359 | ||||
| 2023-10-05 | 2023-10-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 20,0000 | -1.470 | -29 | 322.131 | ||||
| 2023-10-05 | 2023-10-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 20,0000 | -442 | -9 | 36.839 | ||||
| 2023-10-05 | 2023-10-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 20,0000 | -442 | -9 | 70.482 | ||||
| 2023-07-06 | 2023-07-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 25,1000 | -451 | -11 | 29.801 | ||||
| 2023-07-06 | 2023-07-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 25,1000 | -1.498 | -38 | 323.601 | ||||
| 2023-07-06 | 2023-07-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 25,1000 | -451 | -11 | 37.281 | ||||
| 2023-07-06 | 2023-07-03 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 25,1000 | -61 | -2 | 8.033 | ||||
| 2023-07-06 | 2023-07-03 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 25,1000 | -336 | -8 | 38.505 | ||||
| 2023-07-06 | 2023-07-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 25,1000 | -451 | -11 | 70.924 | ||||
| 2023-07-03 | 3 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 8.094 | ||||||||
| 2023-04-05 | 2023-04-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 21,1100 | -447 | -9 | 71.375 | ||||
| 2023-04-05 | 2023-04-03 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 21,1100 | -319 | -7 | 38.841 | ||||
| 2023-04-05 | 2023-04-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 21,1100 | -447 | -9 | 37.732 | ||||
| 2023-04-05 | 2023-04-03 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 21,1100 | -376 | -8 | 30.309 | ||||
| 2023-04-05 | 2023-04-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 21,1100 | -1.486 | -31 | 325.099 | ||||
| 2023-04-05 | 2023-04-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 21,1100 | -447 | -9 | 30.252 | ||||
| 2023-01-05 | 2023-01-03 | 4 | Gutierrez-Ramos Jose-Carlos | BCYC | Ordinary Shares | D | 5.750 | 10.750 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Jordan Veronica GH | BCYC | Ordinary Shares | D | 5.750 | 10.750 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 29,0600 | -1.801 | -52 | 71.822 | ||||
| 2023-01-05 | 2023-01-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 17.500 | 73.623 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 29,0600 | -6.000 | -174 | 326.585 | ||||
| 2023-01-05 | 2023-01-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 57.500 | 332.585 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Winter Gregory Paul | BCYC | Ordinary Shares | D | 5.750 | 174.677 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 11.500 | 21.500 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 29,0600 | -1.815 | -53 | 30.685 | ||||
| 2023-01-05 | 2023-01-03 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 17.500 | 32.500 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Kender Richard N | BCYC | Ordinary Shares | D | 5.750 | 10.750 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 29,0600 | -1.817 | -53 | 39.160 | ||||
| 2023-01-05 | 2023-01-03 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 17.500 | 40.977 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 29,0600 | -1.801 | -52 | 30.699 | ||||
| 2023-01-05 | 2023-01-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 17.500 | 32.500 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Bourque Janice | BCYC | Ordinary Shares | D | 5.750 | 10.750 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Smethurst Dominic | BCYC | Ordinary Shares | D | 29,0600 | -1.801 | -52 | 36.699 | ||||
| 2023-01-05 | 2023-01-03 | 4 | Smethurst Dominic | BCYC | Ordinary Shares | D | 17.500 | 38.500 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 29,0600 | -1.801 | -52 | 38.179 | ||||
| 2023-01-05 | 2023-01-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 17.500 | 39.980 | ||||||
| 2022-03-29 | 2022-03-25 | 4 | Milnes Alistair | BCYC | Employee Stock Option (right to buy) | D | 20,12 | 5.155 | 46.845 | |||||
| 2022-03-29 | 2022-03-25 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 20,1200 | 5.155 | 104 | 22.480 | ||||
| 2022-03-29 | 3/A | Milnes Alistair | BCYC | Ordinary Shares | D | 2.325 | ||||||||
| 2022-01-05 | 2022-01-03 | 4 | Jordan Veronica GH | BCYC | Stock Option (right to buy) | D | 60,87 | 10.000 | 10.000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Jordan Veronica GH | BCYC | Ordinary Shares | D | 5.000 | 5.000 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Winter Gregory Paul | BCYC | Stock Option (right to buy) | D | 60,87 | 10.000 | 10.000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Winter Gregory Paul | BCYC | Ordinary Shares | D | 5.000 | 168.927 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Skynner Michael | BCYC | Employee Stock Option (right to buy) | D | 60,87 | 30.000 | 30.000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 15.000 | 56.123 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Smethurst Dominic | BCYC | Employee Stock Option (right to buy) | D | 60,87 | 30.000 | 30.000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Smethurst Dominic | BCYC | Ordinary Shares | D | 15.000 | 21.000 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Lee Kevin | BCYC | Employee Stock Option (right to buy) | D | 60,87 | 100.000 | 100.000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 50.000 | 275.085 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Legault Pierre | BCYC | Stock Option (right to buy) | D | 60,87 | 20.000 | 20.000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 10.000 | 10.000 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Kender Richard N | BCYC | Stock Option (right to buy) | D | 60,87 | 10.000 | 10.000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Kender Richard N | BCYC | Ordinary Shares | D | 5.000 | 5.000 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Kalowski Lee | BCYC | Employee Stock Option (right to buy) | D | 60,87 | 30.000 | 30.000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 15.000 | 15.000 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Keen Nicholas | BCYC | Employee Stock Option (right to buy) | D | 60,87 | 30.000 | 30.000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 15.000 | 23.477 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Gutierrez-Ramos Jose-Carlos | BCYC | Stock Option (right to buy) | D | 60,87 | 10.000 | 10.000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Gutierrez-Ramos Jose-Carlos | BCYC | Ordinary Shares | D | 5.000 | 5.000 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 60,87 | 30.000 | 30.000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 15.000 | 15.000 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Bourque Janice | BCYC | Stock Option (right to buy) | D | 60,87 | 10.000 | 10.000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Bourque Janice | BCYC | Ordinary Shares | D | 5.000 | 5.000 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Milnes Alistair | BCYC | Employee Stock Option (right to buy) | D | 60,87 | 100.000 | 100.000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 15.000 | 15.000 | ||||||
| 2021-12-22 | 2021-12-21 | 4 | Keen Nicholas | BCYC | Stock Option (Right to Buy) | D | 14,00 | -15.477 | 161.927 | |||||
| 2021-12-22 | 2021-12-21 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 14,0000 | 15.477 | 217 | 15.477 | ||||
| 2021-12-22 | 2021-12-22 | 4 | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 8,48 | -97.860 | 23.312 | |||||
| 2021-12-22 | 2021-12-22 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 58,0100 | -97.860 | -5.677 | 0 | ||||
| 2021-12-22 | 2021-12-22 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 8,4800 | 97.860 | 830 | 97.860 | ||||
| 2021-12-22 | 2021-12-21 | 4 | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 8,44 | -44.537 | 121.172 | |||||
| 2021-12-22 | 2021-12-21 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 57,1100 | -44.537 | -2.544 | 0 | ||||
| 2021-12-22 | 2021-12-21 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 8,4400 | 44.537 | 376 | 44.537 | ||||
| 2021-12-22 | 2021-12-20 | 4 | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 8,41 | -7.603 | 165.709 | |||||
| 2021-12-22 | 2021-12-20 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 57,0200 | -7.603 | -434 | 0 | ||||
| 2021-12-22 | 2021-12-20 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 8,4100 | 7.603 | 64 | 7.603 | ||||
| 2021-10-18 | 2021-10-18 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 60,0000 | -49 | -3 | 225.085 | ||||
| 2021-10-18 | 2021-10-15 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 60,0500 | -320 | -19 | 225.134 | ||||
| 2021-10-18 | 2021-10-14 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 60,0000 | -4.631 | -278 | 225.454 | ||||
| 2021-10-13 | 2021-10-11 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 54,6700 | -598 | -33 | 230.085 | ||||
| 2021-10-13 | 2021-10-11 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 53,7700 | -4.402 | -237 | 230.683 | ||||
| 2021-10-05 | 2021-10-05 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 45,1000 | -2.178 | -98 | 0 | ||||
| 2021-10-05 | 2021-10-01 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 45,0000 | -1.188 | -53 | 2.178 | ||||
| 2021-09-27 | 2021-09-23 | 4 | Smethurst Dominic | BCYC | Employee Stock Option (right to buy) | D | 18,55 | -6.000 | 114.000 | |||||
| 2021-09-27 | 2021-09-23 | 4 | Smethurst Dominic | BCYC | Ordinary Shares | D | 18,5500 | 6.000 | 111 | 6.000 | ||||
| 2021-09-17 | 2021-09-16 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 45,0100 | -1.955 | -88 | 3.366 | ||||
| 2021-09-17 | 2021-09-15 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 45,0000 | -3.000 | -135 | 5.321 | ||||
| 2021-09-03 | 2021-09-02 | 4 | Kalowski Lee | BCYC | Employee Stock Option (right to buy) | D | 9,82 | -10.000 | 50.000 | |||||
| 2021-09-03 | 2021-09-02 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 40,0000 | -10.000 | -400 | 0 | ||||
| 2021-09-03 | 2021-09-02 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 9,8200 | 10.000 | 98 | 10.000 | ||||
| 2021-09-03 | 2021-09-02 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 40,0000 | -10.000 | -400 | 8.321 | ||||
| 2021-09-03 | 2021-09-02 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 40,0000 | -5.000 | -200 | 235.085 | ||||
| 2021-09-03 | 2021-09-01 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | -22.890 | 306.252 | |||||
| 2021-09-03 | 2021-09-01 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 38,0800 | -1.796 | -68 | 240.085 | ||||
| 2021-09-03 | 2021-09-01 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 37,5200 | -17.098 | -642 | 241.881 | ||||
| 2021-09-03 | 2021-09-01 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 36,3800 | -8.191 | -298 | 258.979 | ||||
| 2021-09-03 | 2021-09-01 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 22.890 | 320 | 267.170 | ||||
| 2021-08-31 | 2021-08-31 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | -10.420 | 329.142 | |||||
| 2021-08-31 | 2021-08-31 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 37,0800 | -1.272 | -47 | 244.280 | ||||
| 2021-08-31 | 2021-08-31 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 36,2300 | -9.953 | -361 | 245.552 | ||||
| 2021-08-31 | 2021-08-31 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 10.420 | 146 | 255.505 | ||||
| 2021-08-31 | 2021-08-27 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | -1.808 | 339.562 | |||||
| 2021-08-31 | 2021-08-27 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 36,0200 | -1.808 | -65 | 245.085 | ||||
| 2021-08-31 | 2021-08-27 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 1.808 | 25 | 246.893 | ||||
| 2021-08-27 | 2021-08-27 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 8,73 | -7.950 | 5.768 | |||||
| 2021-08-27 | 2021-08-27 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 35,1500 | -7.950 | -279 | 0 | ||||
| 2021-08-27 | 2021-08-27 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 8,7300 | 7.950 | 69 | 7.950 | ||||
| 2021-08-27 | 2021-08-26 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 8,76 | -550 | 13.718 | |||||
| 2021-08-27 | 2021-08-26 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 35,0400 | -550 | -19 | 0 | ||||
| 2021-08-27 | 2021-08-26 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 8,7600 | 550 | 5 | 550 | ||||
| 2021-08-25 | 2021-08-23 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 1,60 | -7.500 | 59.774 | |||||
| 2021-08-25 | 2021-08-23 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 33,0200 | -7.500 | -248 | 0 | ||||
| 2021-08-25 | 2021-08-23 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 1,6000 | 7.500 | 12 | 7.500 | ||||
| 2021-07-30 | 2021-07-29 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 1,63 | -12.500 | 67.274 | |||||
| 2021-07-30 | 2021-07-29 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 32,8100 | -300 | -10 | 0 | ||||
| 2021-07-30 | 2021-07-29 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 32,1300 | -3.204 | -103 | 300 | ||||
| 2021-07-30 | 2021-07-29 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 31,2400 | -8.996 | -281 | 3.504 | ||||
| 2021-07-30 | 2021-07-29 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 1,6300 | 12.500 | 20 | 12.500 | ||||
| 2021-07-27 | 2021-07-26 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | -100 | 341.370 | |||||
| 2021-07-27 | 2021-07-26 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 36,0000 | -100 | -4 | 245.085 | ||||
| 2021-07-27 | 2021-07-26 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 100 | 1 | 245.185 | ||||
| 2021-07-27 | 2021-07-23 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | -4.782 | 341.470 | |||||
| 2021-07-27 | 2021-07-23 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 36,0200 | -4.782 | -172 | 245.085 | ||||
| 2021-07-27 | 2021-07-23 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 4.782 | 67 | 249.867 | ||||
| 2021-07-20 | 2021-07-14 | 4/A | BINGHAM KATE By SV Life Sciences Fund V Strategic Partners, L.P. | BCYC | Ordinary Shares | I | 34,0076 | -917 | -31 | 38.708 | ||||
| 2021-07-20 | 2021-07-14 | 4/A | BINGHAM KATE By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 34,0076 | -43.378 | -1.475 | 1.831.671 | ||||
| 2021-07-20 | 2021-07-13 | 4/A | BINGHAM KATE By SV Life Sciences Fund V Strategic Partners, L.P. | BCYC | Ordinary Shares | I | 33,5000 | -12 | -0 | 39.625 | ||||
| 2021-07-20 | 2021-07-13 | 4/A | BINGHAM KATE By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 33,5000 | -588 | -20 | 1.875.049 | ||||
| 2021-07-16 | 2021-07-14 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 35,0000 | -10.000 | -350 | 18.321 | ||||
| 2021-07-16 | 2021-07-16 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | -609 | 346.252 | |||||
| 2021-07-16 | 2021-07-16 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 34,0000 | -609 | -21 | 245.085 | ||||
| 2021-07-16 | 2021-07-16 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 609 | 9 | 245.694 | ||||
| 2021-07-16 | 2021-07-15 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | -21.970 | 346.861 | |||||
| 2021-07-16 | 2021-07-15 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 34,2800 | -21.970 | -753 | 245.085 | ||||
| 2021-07-16 | 2021-07-15 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 21.970 | 308 | 267.055 | ||||
| 2021-07-15 | 2021-07-14 | 4 | BINGHAM KATE By SV Life Sciences Fund V Strategic Partners, L.P. | BCYC | Ordinary Shares | I | 34,0076 | -917 | -31 | 38.708 | ||||
| 2021-07-15 | 2021-07-14 | 4 | BINGHAM KATE By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 34,0076 | -43.378 | -1.475 | 1.831.671 | ||||
| 2021-07-15 | 2021-07-13 | 4 | BINGHAM KATE By SV Life Sciences Fund V Strategic Partners, L.P. | BCYC | Ordinary Shares | I | 33,5000 | -12 | -0 | 39.625 | ||||
| 2021-07-15 | 2021-07-13 | 4 | BINGHAM KATE By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 33,5000 | -588 | -20 | 1.875.049 | ||||
| 2021-07-14 | 2021-07-14 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | -8.331 | 368.831 | |||||
| 2021-07-14 | 2021-07-14 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 35,1600 | -53 | -2 | 245.085 | ||||
| 2021-07-14 | 2021-07-14 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 34,8900 | -9.084 | -317 | 245.138 | ||||
| 2021-07-14 | 2021-07-14 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 33,8500 | -2.686 | -91 | 254.222 | ||||
| 2021-07-14 | 2021-07-14 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 32,9300 | -2.642 | -87 | 256.908 | ||||
| 2021-07-14 | 2021-07-14 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 8.331 | 117 | 259.550 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | -35.446 | 377.162 | |||||
| 2021-07-14 | 2021-07-13 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 34,0000 | -11.194 | -381 | 251.219 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 33,0900 | -5.788 | -192 | 262.413 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 32,4200 | -21.979 | -713 | 268.201 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 35.446 | 496 | 290.180 | ||||
| 2021-07-14 | 2021-07-12 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | -1.936 | 412.608 | |||||
| 2021-07-14 | 2021-07-12 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 32,0400 | -1.936 | -62 | 254.734 | ||||
| 2021-07-14 | 2021-07-12 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 1.936 | 27 | 256.670 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 15,36 | -13.019 | 30.764 | |||||
| 2021-07-14 | 2021-07-13 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 9,82 | -19.256 | 38.750 | |||||
| 2021-07-14 | 2021-07-13 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 11,66 | -40.426 | 62.660 | |||||
| 2021-07-14 | 2021-07-13 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 33,0900 | -3.121 | -103 | 0 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 32,4100 | -69.580 | -2.255 | 3.121 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 15,3600 | 13.019 | 200 | 72.701 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 9,8200 | 19.256 | 189 | 59.682 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 11,6600 | 40.426 | 471 | 40.426 | ||||
| 2021-07-14 | 2021-07-12 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 15,36 | -974 | 43.783 | |||||
| 2021-07-14 | 2021-07-12 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 9,82 | -1.723 | 58.006 | |||||
| 2021-07-14 | 2021-07-12 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 11,66 | -4.331 | 103.086 | |||||
| 2021-07-14 | 2021-07-12 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 32,0300 | -7.028 | -225 | 0 | ||||
| 2021-07-14 | 2021-07-12 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 15,3600 | 974 | 15 | 7.028 | ||||
| 2021-07-14 | 2021-07-12 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 9,8200 | 1.723 | 17 | 6.054 | ||||
| 2021-07-14 | 2021-07-12 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 11,6600 | 4.331 | 50 | 4.331 | ||||
| 2021-07-08 | 2021-07-06 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 9,82 | -271 | 59.729 | |||||
| 2021-07-08 | 2021-07-06 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 32,0000 | -271 | -9 | 0 | ||||
| 2021-07-08 | 2021-07-06 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 9,8200 | 271 | 3 | 271 | ||||
| 2021-05-10 | 2021-05-07 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | -5.604 | 414.544 | |||||
| 2021-05-10 | 2021-05-07 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 32,2300 | -5.604 | -181 | 254.734 | ||||
| 2021-05-10 | 2021-05-07 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 5.604 | 78 | 260.338 | ||||
| 2021-05-10 | 2021-05-06 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | -1.716 | 420.148 | |||||
| 2021-05-10 | 2021-05-06 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 32,1400 | -1.716 | -55 | 254.734 | ||||
| 2021-05-10 | 2021-05-06 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 1.716 | 24 | 256.450 | ||||
| 2021-05-05 | 2021-05-04 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | -897 | 421.864 | |||||
| 2021-05-05 | 2021-05-04 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 32,0300 | -897 | -29 | 254.734 | ||||
| 2021-05-05 | 2021-05-04 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 897 | 13 | 255.631 | ||||
| 2021-05-05 | 2021-05-03 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14,00 | -3.391 | 422.761 | |||||
| 2021-05-05 | 2021-05-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 32,1600 | -3.391 | -109 | 254.734 | ||||
| 2021-05-05 | 2021-05-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 3.391 | 47 | 258.125 | ||||
| 2021-04-30 | 2021-04-30 | 4 | Lee Kevin | BCYC | Stock Option (Right to Buy) | D | 14,00 | -30.406 | 426.152 | |||||
| 2021-04-30 | 2021-04-30 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 30,8800 | -26.635 | -822 | 254.734 | ||||
| 2021-04-30 | 2021-04-30 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 29,8900 | -3.771 | -113 | 281.369 | ||||
| 2021-04-30 | 2021-04-30 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 30.406 | 426 | 285.140 | ||||
| 2021-04-30 | 2021-04-29 | 4 | Lee Kevin | BCYC | Stock Option (Right to Buy) | D | 14,00 | -6.018 | 456.558 | |||||
| 2021-04-30 | 2021-04-29 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 30,9500 | -1.609 | -50 | 254.734 | ||||
| 2021-04-30 | 2021-04-29 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 30,3500 | -4.409 | -134 | 256.343 | ||||
| 2021-04-30 | 2021-04-29 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 6.018 | 84 | 260.752 | ||||
| 2021-04-30 | 2021-04-28 | 4 | Lee Kevin | BCYC | Stock Option (Right to Buy) | D | 14,00 | -22.495 | 462.576 | |||||
| 2021-04-30 | 2021-04-28 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 33,3500 | -200 | -7 | 254.734 | ||||
| 2021-04-30 | 2021-04-28 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 32,3000 | -1.460 | -47 | 254.934 | ||||
| 2021-04-30 | 2021-04-28 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 31,2200 | -14.348 | -448 | 256.394 | ||||
| 2021-04-30 | 2021-04-28 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 30,4300 | -6.487 | -197 | 270.742 | ||||
| 2021-04-30 | 2021-04-28 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 22.495 | 315 | 277.229 | ||||
| 2021-04-28 | 2021-04-27 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 31,4100 | -358 | -11 | 254.734 | ||||
| 2021-04-28 | 2021-04-27 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 30,6600 | -6.278 | -192 | 255.092 | ||||
| 2021-04-28 | 2021-04-27 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 6.636 | 93 | 261.370 | ||||
| 2021-04-28 | 2021-04-26 | 4 | Lee Kevin | BCYC | Stock Option (Right to Buy) | D | 14,00 | -6.636 | 485.071 | |||||
| 2021-04-28 | 2021-04-26 | 4 | Lee Kevin | BCYC | Stock Option (Right to Buy) | D | 14,00 | -14.545 | 491.707 | |||||
| 2021-04-28 | 2021-04-26 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 31,5000 | -13.896 | -438 | 254.734 | ||||
| 2021-04-28 | 2021-04-26 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 30,6300 | -4.715 | -144 | 268.630 | ||||
| 2021-04-28 | 2021-04-26 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14,0000 | 14.545 | 204 | 273.345 | ||||
| 2021-04-09 | 2021-04-08 | 4 | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 8,74 | -24.838 | 173.312 | |||||
| 2021-04-09 | 2021-04-08 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 32,1300 | -239 | -8 | 0 | ||||
| 2021-04-09 | 2021-04-08 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 31,4000 | -12.099 | -380 | 239 | ||||
| 2021-04-09 | 2021-04-08 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 32,0000 | -12.500 | -400 | 12.338 | ||||
| 2021-04-09 | 2021-04-08 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 8,7400 | 24.838 | 217 | 24.838 | ||||
| 2021-04-07 | 2021-04-05 | 4 | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 8,83 | -162 | 198.150 | |||||
| 2021-04-07 | 2021-04-05 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 31,0700 | -162 | -5 | 0 | ||||
| 2021-04-07 | 2021-04-05 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 8,8300 | 162 | 1 | 162 | ||||
| 2021-04-02 | 2021-03-31 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 30,0000 | -10.000 | -300 | 28.321 | ||||
| 2021-04-02 | 2021-03-31 | 4 | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 8,78 | -10.000 | 198.312 | |||||
| 2021-04-02 | 2021-03-31 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 30,0000 | -10.000 | -300 | 0 | ||||
| 2021-04-02 | 2021-03-31 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 8,7800 | 10.000 | 88 | 10.000 | ||||
| 2021-03-19 | 2021-03-17 | 4 | Gutierrez-Ramos Jose-Carlos | BCYC | Stock Option (right to buy) | D | 27,90 | 32.000 | 32.000 | |||||
| 2021-03-19 | 2021-03-17 | 4 | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 8,85 | -7.784 | 208.312 | |||||
| 2021-03-19 | 2021-03-17 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 29,0000 | -7.784 | -226 | 0 | ||||
| 2021-03-19 | 2021-03-17 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 8,8500 | 7.784 | 69 | 7.784 | ||||
| 2021-03-16 | 2021-03-12 | 4 | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 8,86 | -2.216 | 216.096 | |||||
| 2021-03-16 | 2021-03-12 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 29,0000 | -2.216 | -64 | 0 | ||||
| 2021-03-16 | 2021-03-12 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 8,8600 | 2.216 | 20 | 2.216 | ||||
| 2021-03-16 | 2021-03-15 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 28,0000 | -217 | -6 | 38.321 | ||||
| 2021-03-16 | 2021-03-12 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 29,0000 | -283 | -8 | 38.538 | ||||
| 2021-03-16 | 2021-03-12 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 28,4800 | -9.500 | -271 | 38.821 | ||||
| 2021-02-09 | 2021-02-05 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 31,0000 | -100 | -3 | 258.800 | ||||
| 2021-01-21 | 2021-01-20 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 33,0000 | -351 | -12 | 258.900 | ||||
| 2021-01-21 | 2021-01-20 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 32,0200 | -100 | -3 | 259.251 | ||||
| 2021-01-21 | 2021-01-20 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 31,3272 | -734 | -23 | 259.351 | ||||
| 2021-01-21 | 2021-01-19 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 31,0900 | -100 | -3 | 260.085 | ||||
| 2021-01-21 | 2021-01-19 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 30,2193 | -371 | -11 | 260.185 | ||||
| 2021-01-21 | 2021-01-19 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 29,1389 | -4.529 | -132 | 260.556 | ||||
| 2021-01-21 | 2021-01-19 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 1,59 | -15.000 | 79.774 | |||||
| 2021-01-21 | 2021-01-19 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 30,0000 | -15.000 | -450 | 0 | ||||
| 2021-01-21 | 2021-01-19 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 1,5900 | 15.000 | 24 | 15.000 | ||||
| 2021-01-15 | 2021-01-14 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 1,60 | -10.000 | 94.774 | |||||
| 2021-01-15 | 2021-01-14 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 25,0000 | -10.000 | -250 | 0 | ||||
| 2021-01-15 | 2021-01-14 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 1,6000 | 10.000 | 16 | 10.000 | ||||
| 2021-01-15 | 2021-01-15 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 27,0100 | -5.000 | -135 | 265.085 | ||||
| 2021-01-15 | 2021-01-14 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 25,0000 | -5.000 | -125 | 270.085 | ||||
| 2021-01-05 | 2021-01-04 | 4 | Winter Gregory Paul | BCYC | Stock Option (right to buy) | D | 17,95 | 19.000 | 19.000 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Smethurst Dominic | BCYC | Employee Stock Option (right to buy) | D | 17,95 | 27.621 | 27.621 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Skynner Michael | BCYC | Employee Stock Option (right to buy) | D | 17,95 | 70.500 | 70.500 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Legault Pierre | BCYC | Stock Option (right to buy) | D | 17,95 | 38.000 | 38.000 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Lee Kevin | BCYC | Employee Stock Option (right to buy) | D | 17,95 | 250.000 | 250.000 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Kender Richard N | BCYC | Stock Option (right to buy) | D | 17,95 | 19.000 | 19.000 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Keen Nicholas | BCYC | Employee Stock Option (right to buy) | D | 17,95 | 70.500 | 70.500 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Kalowski Lee | BCYC | Employee Stock Option (right to buy) | D | 17,95 | 70.500 | 70.500 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Jordan Veronica GH | BCYC | Stock Option (right to buy) | D | 17,95 | 19.000 | 19.000 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 17,95 | 70.500 | 70.500 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Bourque Janice | BCYC | Stock Option (right to buy) | D | 17,95 | 19.000 | 19.000 | |||||
| 2021-01-05 | 2021-01-04 | 4 | BINGHAM KATE | BCYC | Stock Option (right to buy) | D | 17,95 | 19.000 | 19.000 | |||||
| 2020-12-03 | 2020-12-01 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 1,56 | -7.500 | 104.774 | |||||
| 2020-12-03 | 2020-12-01 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 22,5000 | -7.500 | -169 | 0 | ||||
| 2020-12-03 | 2020-12-01 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 1,5600 | 7.500 | 12 | 7.500 | ||||
| 2020-11-30 | 2020-11-27 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 1,56 | -530 | 112.274 | |||||
| 2020-11-30 | 2020-11-27 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 20,0000 | -530 | -11 | 0 | ||||
| 2020-11-30 | 2020-11-27 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 1,5600 | 530 | 1 | 530 | ||||
| 2020-11-25 | 2020-11-25 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 1,56 | -9.781 | 112.804 | |||||
| 2020-11-25 | 2020-11-25 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 20,0700 | -9.781 | -196 | 0 | ||||
| 2020-11-25 | 2020-11-25 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 1,5600 | 9.781 | 15 | 9.781 | ||||
| 2020-11-25 | 2020-11-23 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 1,56 | -17.189 | 122.585 | |||||
| 2020-11-25 | 2020-11-23 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 20,3800 | -213 | -4 | 0 | ||||
| 2020-11-25 | 2020-11-23 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 19,8200 | -16.976 | -336 | 213 | ||||
| 2020-11-25 | 2020-11-23 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 1,5600 | 17.189 | 27 | 17.189 | ||||
| 2020-09-18 | 2020-07-15 | 4 | GLAXOSMITHKLINE PLC | BCYC | Common Stock | I | 19,2500 | -78 | -2 | 1.910.531 | ||||
| 2020-09-18 | 2020-07-15 | 4 | GLAXOSMITHKLINE PLC | BCYC | Common Stock | I | 19,4016 | -3.069 | -60 | 1.910.609 | ||||
| 2020-09-18 | 2020-07-14 | 4 | GLAXOSMITHKLINE PLC | BCYC | Common Stock | I | 19,2740 | -1.597 | -31 | 1.913.678 | ||||
| 2020-08-25 | 2020-08-21 | 4 | Smethurst Dominic | BCYC | Employee Stock Option (right to buy) | D | 18,55 | 120.000 | 120.000 | |||||
| 2020-04-27 | 2019-06-28 | 4/A | Keen Nicholas | BCYC | Stock Option (Right to Buy) | D | 14,00 | 177.404 | 177.404 | |||||
| 2020-04-27 | 2019-06-28 | 4/A | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 14,00 | 283.414 | 283.414 | |||||
| 2020-04-27 | 2019-06-28 | 4/A | Skynner Michael | BCYC | Stock Option (Right to Buy) | D | 14,00 | 183.895 | 183.895 | |||||
| 2020-04-27 | 2019-06-28 | 4/A | Lee Kevin | BCYC | Stock Option (Right to Buy) | D | 14,00 | 506.252 | 506.252 | |||||
| 2020-04-27 | 2019-06-28 | 4/A | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 14,00 | 116.827 | 116.827 | |||||
| 2020-04-16 | 2020-04-14 | 4 | Winter Gregory Paul | BCYC | Series A Preferred Shares Warrant | D | -71.450 | 71.450 | ||||||
| 2020-04-16 | 2020-04-14 | 4 | Winter Gregory Paul | BCYC | Ordinary Shares | D | 71.450 | 163.927 | ||||||
| 2020-02-25 | 2020-02-21 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 15,36 | 44.757 | 44.757 | |||||
| 2020-01-06 | 2019-09-26 | 4/A | Crockett Nigel | BCYC | Employee Stock Option (Right to Buy) | D | 11,66 | 107.417 | 107.417 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Kender Richard N | BCYC | Stock Option (right to buy) | D | 9,82 | 8.202 | 8.202 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Kender Richard N | BCYC | Stock Option (right to buy) | D | 9,82 | 16.000 | 16.000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Legault Pierre | BCYC | Stock Option (right to buy) | D | 9,82 | 32.000 | 32.000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Bourque Janice | BCYC | Stock Option (right to buy) | D | 9,82 | 8.202 | 8.202 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Bourque Janice | BCYC | Stock Option (right to buy) | D | 9,82 | 16.000 | 16.000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 9,82 | 60.000 | 60.000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Jordan Veronica GH | BCYC | Stock Option (right to buy) | D | 9,82 | 16.000 | 16.000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Keen Nicholas | BCYC | Employee Stock Option (right to buy) | D | 9,82 | 60.000 | 60.000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Kalowski Lee | BCYC | Employee Stock Option (right to buy) | D | 9,82 | 60.000 | 60.000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Skynner Michael | BCYC | Employee Stock Option (right to buy) | D | 9,82 | 60.000 | 60.000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Lee Kevin | BCYC | Employee Stock Option (right to buy) | D | 9,82 | 210.000 | 210.000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Winter Gregory Paul | BCYC | Stock Option (right to buy) | D | 9,82 | 16.000 | 16.000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | BINGHAM KATE | BCYC | Stock Option (right to buy) | D | 9,82 | 16.000 | 16.000 | |||||
| 2019-12-19 | 2019-12-17 | 4 | Jordan Veronica GH | BCYC | Stock Option (right to buy) | D | 8,30 | 32.000 | 32.000 | |||||
| 2019-09-30 | 2019-09-26 | 4 | Bourque Janice | BCYC | Stock Option (Right to Buy) | D | 11,66 | 23.798 | 23.798 | |||||
| 2019-09-30 | 2019-09-26 | 4 | Crockett Nigel | BCYC | Employee Stock Option (Right to Buy) | D | 11,66 | 152.174 | 152.174 | |||||
| 2019-09-30 | 2019-09-26 | 4 | Kender Richard N | BCYC | Stock Option (Right to Buy) | D | 11,66 | 23.798 | 23.798 | |||||
| 2019-06-03 | 2019-05-28 | 4 | TYBOURNE CAPITAL MANAGEMENT HK LTD See Footnotes | BCYC | Series B2 Preferred Shares Warrants | I | -139.264 | 0 | ||||||
| 2019-06-03 | 2019-05-28 | 4 | TYBOURNE CAPITAL MANAGEMENT HK LTD See Footnotes | BCYC | Ordinary Shares | I | 14,0000 | 364.286 | 5.100 | 1.957.961 | ||||
| 2019-06-03 | 2019-05-28 | 4 | TYBOURNE CAPITAL MANAGEMENT HK LTD See Footnotes | BCYC | Ordinary Shares | I | 139.264 | 1.593.675 | ||||||
| 2019-06-03 | 2019-05-28 | 4 | TYBOURNE CAPITAL MANAGEMENT HK LTD See Footnotes | BCYC | Ordinary Shares | I | 1.454.411 | 1.454.411 | ||||||
| 2019-06-03 | 2019-05-24 | 4 | TYBOURNE CAPITAL MANAGEMENT HK LTD See Footnotes | BCYC | Series B2 Preferred Shares | I | -1.454.411 | 0 | ||||||
| 2019-05-31 | 2019-05-28 | 4/A | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Series B2 Preferred Shares | I | -206.767 | 0 | ||||||
| 2019-05-31 | 2019-05-28 | 4/A | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Series B1 Preferred Shares Warrants | I | -141.668 | 0 | ||||||
| 2019-05-31 | 2019-05-28 | 4/A | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Series B1 Preferred Shares | I | -1.272.733 | 0 | ||||||
| 2019-05-31 | 2019-05-28 | 4/A | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Ordinary Shares | I | 206.767 | 1.427.151 | ||||||
| 2019-05-31 | 2019-05-28 | 4/A | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Ordinary Shares | I | 141.668 | 1.207.410 | ||||||
| 2019-05-31 | 2019-05-28 | 4/A | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Ordinary Shares | I | 1.272.733 | 1.081.823 | ||||||
| 2019-05-31 | 2019-05-29 | 4 | Cambridge Innovation Capital (Jersey) Ltd | BCYC | Ordinary Shares | D | 14,0000 | 314.286 | 4.400 | 1.751.437 | ||||
| 2019-05-31 | 2019-05-28 | 4 | Cambridge Innovation Capital (Jersey) Ltd | BCYC | Series B2 Preferred Shares | D | -229.741 | 0 | ||||||
| 2019-05-31 | 2019-05-28 | 4 | Cambridge Innovation Capital (Jersey) Ltd | BCYC | Series B1 Preferred Shares Warrants | D | -125.587 | 0 | ||||||
| 2019-05-31 | 2019-05-28 | 4 | Cambridge Innovation Capital (Jersey) Ltd | BCYC | Series B1 Preferred Shares | D | -1.081.823 | 0 | ||||||
| 2019-05-31 | 2019-05-28 | 4 | Cambridge Innovation Capital (Jersey) Ltd | BCYC | Ordinary Shares | D | 229.741 | 1.437.151 | ||||||
| 2019-05-31 | 2019-05-28 | 4 | Cambridge Innovation Capital (Jersey) Ltd | BCYC | Ordinary Shares | D | 125.587 | 1.207.410 | ||||||
| 2019-05-31 | 2019-05-28 | 4 | Cambridge Innovation Capital (Jersey) Ltd | BCYC | Ordinary Shares | D | 1.081.823 | 1.081.823 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Vertex Global Healthcare Fund I Pte Ltd. | BCYC | Series B2 Preferred Shares | D | -206.767 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Vertex Global Healthcare Fund I Pte Ltd. | BCYC | Series B1 Preferred Shares Warrants | D | -141.668 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Vertex Global Healthcare Fund I Pte Ltd. | BCYC | Series B1 Preferred Shares | D | -1.272.733 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Vertex Global Healthcare Fund I Pte Ltd. | BCYC | Ordinary Shares | D | 206.767 | 1.621.168 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Vertex Global Healthcare Fund I Pte Ltd. | BCYC | Ordinary Shares | D | 141.668 | 1.414.401 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Vertex Global Healthcare Fund I Pte Ltd. | BCYC | Ordinary Shares | D | 1.272.733 | 1.272.733 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Keen Nicholas | BCYC | Stock Option (Right to Buy) | D | 14,00 | 177.404 | 177.404 | |||||
| 2019-05-30 | 2019-05-28 | 4 | Skynner Michael | BCYC | Stock Option (Right to Buy) | D | 14,00 | 183.895 | 183.895 | |||||
| 2019-05-30 | 2019-05-28 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 14,00 | 283.414 | 283.414 | |||||
| 2019-05-30 | 2019-05-28 | 4 | Leone Peter Brian | BCYC | Stock Option (Right to Buy) | D | 14,00 | 43.269 | 43.269 | |||||
| 2019-05-30 | 2019-05-28 | 4 | Lee Kevin | BCYC | Stock Option (Right to Buy) | D | 14,00 | 506.252 | 506.252 | |||||
| 2019-05-30 | 2019-05-28 | 4 | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 14,00 | 116.827 | 116.827 | |||||
| 2019-05-30 | 2019-05-28 | 4 | HARLAND DEBORAH | BCYC | Series B1 Preferred Shares | I | -636.366 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | HARLAND DEBORAH | BCYC | Series A Preferred Shares | I | -893.195 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | HARLAND DEBORAH | BCYC | Ordinary Shares | I | 14,0000 | 385.714 | 5.400 | 1.915.275 | ||||
| 2019-05-30 | 2019-05-28 | 4 | HARLAND DEBORAH | BCYC | Ordinary Shares | I | 636.366 | 1.529.561 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | HARLAND DEBORAH | BCYC | Ordinary Shares | I | 893.195 | 893.195 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Series B1 Preferred Shares | I | -13.169 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Series A Preferred Shares | I | -18.485 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V, L.P. | BCYC | Series B1 Preferred Shares | I | -623.196 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V, L.P. | BCYC | Series A Preferred Shares | I | -874.709 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Ordinary Shares | I | 14,0000 | 7.983 | 112 | 39.637 | ||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 14,0000 | 377.732 | 5.288 | 1.875.637 | ||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Ordinary Shares | I | 13.169 | 31.654 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Ordinary Shares | I | 18.485 | 18.485 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 623.196 | 1.497.905 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 874.709 | 874.709 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Anstey Michael By Cambridge Innovation Capital (Jersey) Limited | BCYC | Series B2 Preferred Shares | I | 229.741 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Anstey Michael By Cambridge Innovation Capital (Jersey) Limited | BCYC | Series B1 Preferred Shares Warrants | I | 125.587 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Anstey Michael By Cambridge Innovation Capital (Jersey) Limited | BCYC | Series B1 Preferred Shares | I | 1.081.823 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Anstey Michael By Cambridge Innovation Capital (Jersey) Limited | BCYC | Ordinary Shares | I | 14,0000 | 314.286 | 4.400 | 1.751.437 | ||||
| 2019-05-30 | 2019-05-28 | 4 | Anstey Michael By Cambridge Innovation Capital (Jersey) Limited | BCYC | Ordinary Shares | I | 229.741 | 1.437.151 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Anstey Michael By Cambridge Innovation Capital (Jersey) Limited | BCYC | Ordinary Shares | I | 125.587 | 1.207.410 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Anstey Michael By Cambridge Innovation Capital (Jersey) Limited | BCYC | Ordinary Shares | I | 1.081.823 | 1.081.823 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Series B1 Preferred Shares | I | -13.169 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Series A Preferred Shares | I | -18.485 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V, L.P. | BCYC | Series B1 Preferred Shares | I | -623.196 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V, L.P. | BCYC | Series A Preferred Shares | I | -874.709 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Ordinary Shares | I | 14,0000 | 7.983 | 112 | 39.637 | ||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 14,0000 | 377.732 | 5.288 | 1.875.637 | ||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Ordinary Shares | I | 13.169 | 31.654 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Ordinary Shares | I | 18.485 | 18.485 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 623.196 | 1.497.905 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 874.709 | 874.709 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Series B2 Preferred Shares | I | -206.767 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Series B1 Preferred Shares Warrants | I | -141.668 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Series B1 Preferred Shares | I | -1.272.733 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Ordinary Shares | I | 206.767 | 1.621.168 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Ordinary Shares | I | 141.668 | 1.414.401 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Ordinary Shares | I | 1.272.733 | 1.272.733 | ||||||
| 2019-05-30 | 2019-05-27 | 4 | NG CAROLYN By Vertex Venture Management PTE LTD. | BCYC | Ordinary Shares | I | 14,0000 | 571.429 | 8.000 | 571.429 | ||||
| 2019-05-30 | 2019-05-28 | 4 | Winter Gregory Paul | BCYC | Series A Preferred Shares | D | -42.870 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Winter Gregory Paul | BCYC | Ordinary Shares | D | 42.870 | 92.477 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Novartis Bioventures Ltd | BCYC | Series B1 Preferred Shares | D | -636.366 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Novartis Bioventures Ltd | BCYC | Series A Preferred Shares Warrants | D | -71.450 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Novartis Bioventures Ltd | BCYC | Series A Preferred Shares | D | -893.195 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Novartis Bioventures Ltd | BCYC | Ordinary Shares | D | 14,0000 | 168.630 | 2.361 | 1.769.641 | ||||
| 2019-05-30 | 2019-05-28 | 4 | Novartis Bioventures Ltd | BCYC | Ordinary Shares | D | 636.366 | 1.601.011 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Novartis Bioventures Ltd | BCYC | Ordinary Shares | D | 71.450 | 964.645 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Novartis Bioventures Ltd | BCYC | Ordinary Shares | D | 893.195 | 893.195 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | GLAXOSMITHKLINE PLC | BCYC | Series B1 Preferred Shares | I | -445.323 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | GLAXOSMITHKLINE PLC | BCYC | Series A Preferred Shares | I | -625.049 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | GLAXOSMITHKLINE PLC | BCYC | Ordinary Shares | I | 14,0000 | 385.714 | 5.400 | 1.915.275 | ||||
| 2019-05-30 | 2019-05-28 | 4 | GLAXOSMITHKLINE PLC | BCYC | Ordinary Shares | I | 636.366 | 1.529.561 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | GLAXOSMITHKLINE PLC | BCYC | Ordinary Shares | I | 893.195 | 893.195 | ||||||
| 2019-05-22 | 3 | Skynner Michael | BCYC | Ordinary Shares | D | 82.246 | ||||||||
| 2019-05-22 | 3 | Skynner Michael | BCYC | Ordinary Shares | D | 82.246 | ||||||||
| 2019-05-22 | 3 | Skynner Michael | BCYC | Ordinary Shares | D | 82.246 | ||||||||
| 2019-05-22 | 3 | Lee Kevin | BCYC | Ordinary Shares | D | 550.170 | ||||||||
| 2019-05-22 | 3 | Lee Kevin | BCYC | Ordinary Shares | D | 550.170 | ||||||||
| 2019-05-22 | 3 | Lee Kevin | BCYC | Ordinary Shares | D | 550.170 | ||||||||
| 2019-05-22 | 3 | Keen Nicholas | BCYC | Ordinary Shares | D | 96.642 | ||||||||
| 2019-05-22 | 3 | Keen Nicholas | BCYC | Ordinary Shares | D | 96.642 | ||||||||
| 2019-05-22 | 3 | Keen Nicholas | BCYC | Ordinary Shares | D | 96.642 | ||||||||
| 2019-05-22 | 3 | Winter Gregory Paul | BCYC | Ordinary Shares | D | 99.214 | ||||||||
| 2019-05-22 | 3 | Winter Gregory Paul | BCYC | Ordinary Shares | D | 99.214 | ||||||||
| 2019-05-22 | 3 | Winter Gregory Paul | BCYC | Ordinary Shares | D | 99.214 |
P
Acquisto sul mercato aperto o privato di un titolo non derivato o derivato
S
Vendita sul mercato aperto o privato di un titolo non derivato o derivato
A
Concessione, assegnazione o altra acquisizione di titoli dall'azienda (ad esempio un'opzione)
C
Conversione di un derivato
D
Vendita o trasferimento di titoli alla società
F
Pagamento del prezzo di esercizio o del debito fiscale con la quota di titoli ricevuta dalla società
G
Regalo di titoli da parte o a favore dell'insider
K
Equity swap e operazioni di copertura analoghe
M
Esercizio o conversione di un titolo derivato ricevuto dall'azienda (ad esempio un'opzione)
V
Una transazione dichiarata volontariamente sul modulo 4
J
Altro (accompagnato da una nota a piè di pagina che descriva l'operazione)
